133 related articles for article (PubMed ID: 32378183)
1. Prediagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics.
Sandsveden M; Nilsson E; Borgquist S; Rosendahl AH; Manjer J
Int J Cancer; 2020 Nov; 147(9):2424-2436. PubMed ID: 32378183
[TBL] [Abstract][Full Text] [Related]
2. Selenium and breast cancer risk: A prospective nested case-control study on serum selenium levels, smoking habits and overweight.
Sandsveden M; Manjer J
Int J Cancer; 2017 Nov; 141(9):1741-1750. PubMed ID: 28681438
[TBL] [Abstract][Full Text] [Related]
3. Serum selenium levels predict survival after breast cancer.
Lubinski J; Marciniak W; Muszynska M; Huzarski T; Gronwald J; Cybulski C; Jakubowska A; Debniak T; Falco M; Kladny J; Kotsopoulos J; Sun P; Narod SA
Breast Cancer Res Treat; 2018 Jan; 167(2):591-598. PubMed ID: 29043463
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
[TBL] [Abstract][Full Text] [Related]
5. Serum selenium, selenoprotein P and glutathione peroxidase 3 as predictors of mortality and recurrence following breast cancer diagnosis: A multicentre cohort study.
Demircan K; Bengtsson Y; Sun Q; Brange A; Vallon-Christersson J; Rijntjes E; Malmberg M; Saal LH; Rydén L; Borg Å; Manjer J; Schomburg L
Redox Biol; 2021 Nov; 47():102145. PubMed ID: 34563873
[TBL] [Abstract][Full Text] [Related]
6. Serum Selenium Level Predicts 10-Year Survival after Breast Cancer.
Szwiec M; Marciniak W; Derkacz R; Huzarski T; Gronwald J; Cybulski C; Dębniak T; Jakubowska A; Lener M; Falco M; Kładny J; Baszuk P; Duszyński J; Kotsopoulos J; Narod SA; Lubiński J
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809461
[TBL] [Abstract][Full Text] [Related]
7. Risk of breast cancer in relation to dietary intake of selenium and serum selenium as a marker of dietary intake: a prospective cohort study within The Malmö Diet and Cancer Study.
Bengtsson Y; Sandsveden M; Manjer J
Cancer Causes Control; 2021 Aug; 32(8):815-826. PubMed ID: 33914217
[TBL] [Abstract][Full Text] [Related]
8. Selenium intake and breast cancer mortality in a cohort of Swedish women.
Harris HR; Bergkvist L; Wolk A
Breast Cancer Res Treat; 2012 Aug; 134(3):1269-77. PubMed ID: 22736377
[TBL] [Abstract][Full Text] [Related]
9. Association between selenium intake and breast cancer risk: results from the Women's Health Initiative.
Guo D; Hendryx M; Liang X; Manson JE; He K; Vitolins MZ; Li Y; Luo J
Breast Cancer Res Treat; 2020 Aug; 183(1):217-226. PubMed ID: 32607639
[TBL] [Abstract][Full Text] [Related]
10. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.
Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
Carcinogenesis; 2015 Oct; 36(10):1121-8. PubMed ID: 26130675
[TBL] [Abstract][Full Text] [Related]
11. Relatively high mortality risk in elderly Swedish subjects with low selenium status.
Alehagen U; Johansson P; Björnstedt M; Rosén A; Post C; Aaseth J
Eur J Clin Nutr; 2016 Jan; 70(1):91-6. PubMed ID: 26105108
[TBL] [Abstract][Full Text] [Related]
12. Serum Iodine and Breast Cancer Risk: A Prospective Nested Case-Control Study Stratified for Selenium Levels.
Manjer J; Sandsveden M; Borgquist S
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1335-1340. PubMed ID: 32457181
[TBL] [Abstract][Full Text] [Related]
13. Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.
Asleh K; Won JR; Gao D; Voduc KD; Nielsen TO
Breast Cancer Res Treat; 2018 Feb; 168(1):107-115. PubMed ID: 29159761
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Survival Defined by Biological Receptor and Menopausal Status in Vietnamese Women.
Vu Hong T; Nguyen Ba D; Skoog L; Ta Thanh V; Tani E
Cancer Control; 2019; 26(1):1073274819865279. PubMed ID: 31343899
[TBL] [Abstract][Full Text] [Related]
15. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
Guglielmini P; Rubagotti A; Boccardo F
Breast Cancer Res Treat; 2012 Apr; 132(2):661-8. PubMed ID: 22094938
[TBL] [Abstract][Full Text] [Related]
16. Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study.
Li J; Liu L; Feng Z; Wang X; Huang Y; Dai H; Zhang L; Song F; Wang D; Zhang P; Ma B; Li H; Zheng H; Song F; Chen K
Breast Cancer; 2020 Jul; 27(4):621-630. PubMed ID: 32040723
[TBL] [Abstract][Full Text] [Related]
17. The association between serum selenium concentration and prognosis in patients with heart failure in a Chinese population.
Zhang Z; Chang C; Zhang Y; Chai Z; Li J; Qiu C
Sci Rep; 2021 Jul; 11(1):14533. PubMed ID: 34267252
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer in young women and prognosis: How important are proliferation markers?
Fredholm H; Magnusson K; Lindström LS; Tobin NP; Lindman H; Bergh J; Holmberg L; Pontén F; Frisell J; Fredriksson I
Eur J Cancer; 2017 Oct; 84():278-289. PubMed ID: 28844016
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
Yang Y; Qian J; Xiang Y; Chen Y; Qu J
Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
[TBL] [Abstract][Full Text] [Related]
20. Premorbid diet and the prognosis of women with breast cancer.
Jain M; Miller AB; To T
J Natl Cancer Inst; 1994 Sep; 86(18):1390-7. PubMed ID: 8072032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
